Resultats globals: 16 registres trobats en 0.02 segons.
Articles, 10 registres trobats
Documents de recerca, 6 registres trobats
Articles 10 registres trobats  
1.
6 p, 2.0 MB Cerebral gliosarcoma with perivascular involvement in a cat / Álvarez, Patricia (Pride Veterinary Centre, Derby. Neurology and Neurosurgery Service) ; Wessmann, Annette (Pride Veterinary Centre, Derby. Neurology and Neurosurgery Service) ; Pascual, Mireia (BalmesVet. ClínicaVeterinaria (Barcelona)) ; Comas, Oriol (BalmesVet. ClínicaVeterinaria (Barcelona)) ; Pi, Dolors (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Pumarola i Batlle, Martí (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals)
Case summary A 5-year-old neutered male domestic shorthair cat presented with an 18-month history of facial tics, and progressive general ataxia, weakness, lethargy and anorexia of 2 weeks' duration. [...]
2019 - 10.1177/2055116919879783
Journal of feline medicine and surgery, Vol. 5, Num. 2 (2019)  
2.
13 p, 2.4 MB Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461 / Li, Guihong (Zhengzhou, 450000 China) ; Shen, Jing (Department of Cardiology, Shengze Hospital of Jiangsu Province, Suzhou, 215200 China) ; Cao, Junguo (Changchun, 130021 China) ; Zhou, Guangtong (Zhengzhou, 450000 China) ; Lei, Ting (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sun, Yuxue (Changchun, 130021 China) ; Gao, Haijun (Changchun, 130021 China) ; Ding, Yaonan (Changchun, 130021 China) ; Xu, Weidong (Changchun, 130021 China) ; Zhan, Zhixin (Changchun, 130021 China) ; Chen, Yong (Changchun, 130021 China) ; Huang, Haiyan (Changchun, 130021 China) ; Universitat Autònoma de Barcelona
Glioma is a heterogeneous, invasive primary brain tumor with a wide range of patient survival and a lack of reliable prognostic biomarkers. Human telomerase reverse transcriptase (hTERT) has been reported in the presence of multiple transcripts in various tumor systems. [...]
2018 - 10.1186/s13046-018-0749-8
Journal of Experimental & Clinical Cancer Research : CR, Vol. 37 (april 2018)  
3.
9 p, 559.9 KB Long-term follow-up of surgical resection alone for primary intracranial rostrotentorial tumors in dogs : 29 cases (2002-2013) / Suñol, Anna ; Mascort, Joan ; Font, Cristina ; Bastante, Alicia Rami ; Pumarola i Batlle, Martí (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Feliu-Pascual, Alejandro Lujan
Intracranial neoplasia is frequently encountered in dogs. After a presumptive diagnosis of intracranial neoplasia is established based on history, clinical signs and advanced imaging characteristics, the decision to treat and which treatment to choose must be considered. [...]
2017 - 10.4314/ovj.v7i4.14
Open Veterinary Journal, Vol. 7 (december 2017) , p. 375-383  
4.
14 p, 1.9 MB Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer / Rodón, Jordi (Hospital Universitari Vall d'Hebron) ; Carducci, Michael (Johns Hopkins Kimmel Cancer Center) ; Sepulveda-Sánchez, Juan M. (Hospital Universitario 12 de Octubre) ; Azaro, Analía (Hospital Universitari Vall d'Hebron) ; Calvo, Emiliano (START Madrid, Centro Integral Oncológico Clara Campal) ; Seoane, Joan (Hospital Universitari Vall d'Hebron) ; Braña, Irene (Hospital Universitari Vall d'Hebron) ; Sicart, Elisabet (Hospital Universitari Vall d'Hebron) ; Gueorguieva, Ivelina (Eli Lilly and Company) ; Cleverly, Ann (Eli Lilly and Company) ; Pillay, N. Sokalingum (Eli Lilly and Company) ; Desaiah, Durisala (Eli Lilly and Company) ; Estrem, Shawn T. (Eli Lilly and Company) ; Paz-Ares, Luis (Hospital Virgen del Rocío, Sevilla, Spain) ; Holdhoff, Matthias (Johns Hopkins Kimmel Cancer Center) ; Blakeley, Jaishri (Johns Hopkins University) ; Lahn, Michael M. (Eli Lilly and Company) ; Baselga, Jose (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Purpose Transforming growth factor-beta (TGF-β) signaling plays a key role in epithelial-mesenchymal transition (EMT) of tumors, including malignant glioma. Small molecule inhibitors (SMI) blocking TGF-β signaling reverse EMT and arrest tumor progression. [...]
2014 - 10.1007/s10637-014-0192-4
Investigational New Drugs, Vol. 33 (december 2014) , p. 357-370  
5.
29 p, 14.8 MB Metabolomics of Therapy Response in Preclinical Glioblastoma : a Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment / Arias-Ramos, Nuria (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Ferrer-Font, Laura (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Lope Piedrafita, Silvia (Universitat Autònoma de Barcelona. Servei de Ressonància Magnètica Nuclear) ; Mocioiu, Victor (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Julià Sapé, Ma. Margarita (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Pumarola i Batlle, Martí (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ; Arús i Caraltó, Carles (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Candiota Silveira, Ana Paula (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular)
Glioblastoma (GBM) is the most common aggressive primary brain tumor in adults, with a short survival time even after aggressive therapy. Non-invasive surrogate biomarkers of therapy response may be relevant for improving patient survival. [...]
2017 - 10.3390/metabo7020020
Metabolites, Vol. 7, Num. 2 (2017) , p. p1-29  
6.
12 p, 450.2 KB Safety and Efficacy of 5-Aminolevulinic Acid for High Grade Glioma in Usual Clinical Practice: A Prospective Cohort Study / Teixidor, Pilar (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Arráez, Miguel Ángel (Hospital Regional Universitario de Málaga) ; Villalba, Glòria (Hospital del Mar (Barcelona, Catalunya)) ; Garcia, Roser (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Tardáguila, Manel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; González Sánchez, Juan José (Hospital Clínic i Provincial de Barcelona) ; Rimbau, Jordi (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Vidal Guitart, Xavier (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Montané, Eva (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Background: During the last decade, the use of 5-aminolevulinic acid (5-ALA) has been steadily increasing in neurosurgery. The study's main objectives were to prospectively evaluate the effectiveness and safety of 5-ALA when used in clinical practice setting on high-grade gliomas' patients. [...]
2016 - 10.1371/journal.pone.0149244
PloS one, Vol. 11 Núm. 2 (February 2016)  
7.
18 p, 1.8 MB Targeting protein kinase CK2 : evaluationg CX-4945 potential for GL261 glioblastoma therapy in immunocompetent mice / Ferrer-Font, Laura (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Villamañán de Santiago, Lucía (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Arias-Ramos, Nuria (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Vilardell Vilà, Jordi (Università degli studi di Padova. Dipartimento di Scienze Biomediche) ; Plana i Coll, Maria (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Ruzzene, Maria (Università degli studi di Padova. Dipartimento di Scienze Biomediche) ; Pinna, Lorenzo A. (Università degli studi di Padova. Dipartimento di Scienze Biomediche) ; Itarte, Emilio (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Arús i Caraltó, Carles (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Candiota Silveira, Ana Paula (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular)
Glioblastoma (GBM) causes poor survival in patients even with aggressive treatment. Temozolomide (TMZ) is the standard chemotherapeutic choice for GBM treatment but resistance always ensues. Protein kinase CK2 (CK2) contributes to tumour development and proliferation in cancer, and it is overexpressed in human GBM. [...]
2017 - 10.3390/ph10010024
Pharmaceuticals, Vol. 10 Núm. 1 (2017) , p. art 24
2 documents
8.
17 p, 1.8 MB Protein kinase CK2 content in GL261 mouse glioblastoma / Ferrer-Font, Laura (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Alcaraz Muñoz, Estefania (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Plana i Coll, Maria (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Candiota Silveira, Ana Paula (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Itarte, Emilio (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular) ; Arús i Caraltó, Carles (Universitat Autònoma de Barcelona. Departament de Bioquímica i Biologia Molecular)
Glioblastoma (GBM) is the most prevalent and aggressive human glial tumour with a median survival of 14-15 months. Temozolomide (TMZ) is the standard chemotherapeutic choice for GBM treatment. Unfortunately, chemoresistence always ensues with concomitant tumour regrowth. [...]
2016 - 10.1007/s12253-015-9987-7
Pathology & oncology research, Vol. 22, Issue 3 (July 2016) , p. 633-637  
9.
22 p, 433.8 KB Kupfer-type immunological synapses in vivo : Raison D'être of SMAC / Mitxitorena, Izaskun (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Saavedra López, Elena (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Barcia, Carlos (Universitat Autònoma de Barcelona. Institut de Neurociències)
T cells engage with antigen-presenting cells to form immunological synapses. These intimate contacts are characterized by the complex arrangement of molecules at the intercellular interface, which has been described as the supramolecular activation cluster (SMAC). [...]
2015 - 10.1038/icb.2014.80
Immunology and Cell Biology, Vol. 93, no. 1 (2015) , p. 51-56  
10.
10 p, 2.3 MB Imaging the microanatomy of astrocyte-T-cell interactions in immune-mediated inflammation / Barcia, Carlos (Consorci Hospital General Universitari (Valencia). Departament de Neurocirurgia) ; Mitxitorena, Izaskun (Universitat Autònoma de Barcelona. Institut de Neurociències) ; Carrillo-de Sauvage, Maria A. (Institut d'Imagerie Biomédicale) ; Gallego, José Maria (Consorci Hospital General Universitari (Valencia). Departament de Neurocirurgia) ; Pérez-Vallés, Ana (Consorci Hospital General Universitari (Valencia). Departament de Patologia) ; Barcia, Carlos (Universitat Autònoma de Barcelona. Institut de Neurociències)
The role of astrocytes in the immune-mediated inflammatory response in the brain is more prominent than previously thought. Astrocytes become reactive in response to neuro-inflammatory stimuli through multiple pathways, contributing significantly to the machinery that modifies the parenchymal environment. [...]
2013 - 10.3389/fncel.2013.00058
Frontiers in cellular neuroscience, Vol. 7 (April 2013) , p. 1-10  

Documents de recerca 6 registres trobats  
1.
145 p, 6.4 MB Stimulation of Glioma-Associated Microglia/Macrophages effector phagocytic synapse towards tumor clearance in glioma / Saavedra López, Elena, autor. ; Barcia González, Carlos, supervisor acadèmic. ; Aguilera Ávila, José, supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
Glioblastoma (GBM) es el tumor más agresivo dentro de la clasificación de gliomas y actualmente no tiene cura. Dado que hasta el 30% de las células en GBM son microglia y macrófagos (GAMMs desde ahora, por sus siglas en ingles), decidimos estudiarlos para ayudar en el diseño de posibles futuras inmunoterapias. [...]
Glioblastoma (GBM) is the most aggressive form of glioma and currently has no cure. Given that around 30% of the cells within the tumor are microglia/macrophages (glioma- associated microglia/macrophages or GAMM from now on), we decided to study them in order to shed light in possible future immunotherapies. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2019.  
2.
1 p, 2.9 MB From adult neurogenesis to the gliomagenic potential of the subventricular zone : glioma stem cell maintenance in the context of the hypoxic niche : the case of glioblastoma multiforme / Capdevila, Claudia ; Martí Clúa, Joaquim, dir. (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Ciències Biomèdiques [832]  
3.
1 p, 1.0 MB The extracellular matrix (ECM) in canine gliomas: the role of the elements of the ECM in the persistence and invasiveness of canine gliomas / Domingo Curto, Sílvia ; Universitat Autònoma de Barcelona. Facultat de Veterinària
The study of the extracellular matrix (ECM) in the nervous tissue is at a very early stage. Recently, some works have appeared connecting ECM and gliomas to detect diagnostic, prognostic and therapeutic tools being effective in neuroncology. [...]
2014
Grau en Veterinària [955]  
4.
1 p, 1.6 MB The role of angiogenesis in the invasiveness of canine gliomas / Abad Cortel, Etna ; Universitat Autònoma de Barcelona. Facultat de Veterinària
Gliomas are tumors that originate in the central nervous system from glial cells, being glioblastoma the most aggressive tumor, which is characterized by rapid and infiltrative growth, along with a poor prognosis owing to poor response to treatment. [...]
2014
Grau en Veterinària [955]  
5.
202 p, 5.6 MB La Pet amb 11c-metionina com a factor pronòstic i en la caracterització dels gliomes / Mestre i Fusco, Antoni ; Castell Conesa, Joan, dir. (Hospitals Universitaris Vall d'Hebron. Servei de Medicina Nuclear) ; Conesa Bertran, Joan, dir. (Hospitals Universitaris Vall d'Hebron. Servei de Neurocirurgia) ; Alameda, Francesc, dir. (Hospital del Mar (Barcelona, Catalunya). Servei d'Anatomia Patològica) ; Universitat Autònoma de Barcelona. Departament de Medicina
Antecedents: La PET amb metionina és una eina de diagnòstic per la imatge útil per al diagnòstic i seguiment de tumors cerebrals. S'ha descrit la seva utilitat en la valoració de l'agressivitat tumoral tant per a la gradació tumoral com per a la valoració de la proliferació cel·lular en gliomes. [...]
Background: Methionine PET is an imaging diagnostic tool useful in brain tumour diagnosis and follow up. PET utility to assess tumor aggressiveness for tumoral gradation as well as for the study of cell proliferation in gliomas has been described. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2015  
6.
205 p, 3.8 MB New strategies in the treatment of radioresistant tumor cells by using synchrotron radiation and metallic compounds / Gil Duran, Sílvia ; Sabés, Manel, dir. ; Prezado, Yolanda ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
El glioblastoma (multiforme) segueix sent uns dels tumors més letals. Això és conseqüència de l'alta radiosensibilitat del teixit sà del voltant, el que impedeix la deposició de dosis curatives amb les tècniques de radioteràpia convencionals. [...]
Glioblastoma and glioblastoma multiforme are one of the most lethal tumors despite modern treatments. The high morbidity of the surrounding healthy tissues arises as the main obstacle to reach a curative treatment in conventional radiotherapy. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.